This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ciro Valent Sumaya, MD; Lawrence W. Myers, MD; George W. Ellison, MD

Arch Neurol. 1980;37(2):94-96.

Abstract
• Serum antibody titers to Epstein-Barr virus (EBV), an agent that persists in a latent form after the initial infection, were determined in 157 patients with multiple sclerosis and in 81 control subjects. Two patients (1.3%) and five control subjects (6.2%) lacked antibodies to EBV. In the subjects with antibodies, the prevalence of higher titers ( 1:160) was significantly greater in patients, 69 (44.5%), than in control subjects, 22 (28.9%). The geometric mean titer of antibodies to EBV was significantly higher in patients, 107.0, than in control subjects, 77.1. There was no association between antibody titers and duration or activity of the disease. These findings further support the contention that patients with multiple sclerosis have a general aberration of the immunological system.

Author Affiliations
From the Departments of Pediatrics (Dr Sumaya) and Neurology (Drs Myers and Ellison) and the Reed Neurological Research Center (Drs Myers and Ellison), UCLA School of Medicine, Los Angeles. Dr Sumaya is now with the Department of Pediatrics and Pathology, University of Texas Health Science Center, San Antonio.

Footnotes
Accepted for publication Jan 18, 1979.

Reprint requests to Department of Pediatrics, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284 (Dr Sumaya).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study
Sundstrom et al.
Mult Scler 2008;14:1120-1122.
ABSTRACT  

Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain
Serafini et al.
JEM 2007;204:2899-2912.
ABSTRACT | FULL TEXT  

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway
Myhr et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:539-542.
ABSTRACT | FULL TEXT  

B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus
Munch et al.
Mult Scler 1995;1:78-81.
ABSTRACT  

Viral Antibody Titers: Comparison in Patients With Multiple Sclerosis and Rheumatoid Arthritis
Shirodaria et al.
Arch Neurol 1987;44:1237-1241.
ABSTRACT  

Epstein-Barr Virus Infection and Antibody Synthesis in Patients With Multiple Sclerosis
Bray et al.
Arch Neurol 1983;40:406-408.
ABSTRACT  

Intrathecal Interferon in Multiple Sclerosis
Jacobs et al.
Arch Neurol 1982;39:609-615.
ABSTRACT